DR Corp - Public Comps and Valuation Multiples

DR Corp Overview

About DR Corp

DR Corp Ltd is engaged in designing, wholesale, retail and maintenance of jewelry, diamonds, platinum, gold, silver, diamond inlays and their accessories.

Founded

2010

HQ

Employees

n/a

Website

darryring.com

Sectors

Luxury Goods
Clothing & Accessories

Financials

LTM Revenue $218M

LTM EBITDA $49.4M

EV

$1.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

DR Corp Financials

As of September 2025, DR Corp reported last 12-month revenue of $218M and EBITDA of $49.4M.

In the same period, DR Corp generated $143M in LTM gross profit and $15.9M in net income.

See DR Corp valuation multiples based on analyst estimates

DR Corp P&L

In the most recent fiscal year, DR Corp reported revenue of $208M and EBITDA of $52.6M.

DR Corp expects next 12-month revenue of XXX and NTM EBITDA of XXX

See DR Corp valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$218M	XXX	$208M	XXX	XXX	XXX
Gross Profit	$143M	XXX	$136M	XXX	XXX	XXX
Gross Margin	65%	XXX	65%	XXX	XXX	XXX
EBITDA	$49.4M	XXX	$52.6M	XXX	XXX	XXX
EBITDA Margin	23%	XXX	25%	XXX	XXX	XXX
EBIT	$22.3M	XXX	-$9.6M	XXX	XXX	XXX
EBIT Margin	10%	XXX	-5%	XXX	XXX	XXX
Net Profit	$15.9M	XXX	$7.4M	XXX	XXX	XXX
Net Margin	7%	XXX	4%	XXX	XXX	XXX
Net Debt	XXX	XXX	$28.0M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for DR Corp including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $218M. EBITDA for the last twelve months was $49.4M. In the most recent fiscal year, DR Corp achieved $208M in revenue and $52.6M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$218M	Analyst estimates available to subscribers	$208M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$143M	Analyst estimates available to subscribers	$136M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	65.4% gross margin	Analyst estimates available to subscribers	65.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$49.4M	Analyst estimates available to subscribers	$52.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	22.6% EBITDA margin	Analyst estimates available to subscribers	25.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$22.3M	Analyst estimates available to subscribers	-$9.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	10.2% EBIT margin	Analyst estimates available to subscribers	-4.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$15.9M	Analyst estimates available to subscribers	$7.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	7.3% net profit margin	Analyst estimates available to subscribers	3.6% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$28.0M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for DR Corp

This financial data table provides comprehensive performance metrics for DR Corp, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

DR Corp generated $218M in revenue over the last twelve months.
The company achieved $49.4M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $143M.
Net income over the last twelve months reached $15.9M.

Fiscal Year Performance

In the most recent fiscal year, DR Corp reported $208M in total revenue.
Fiscal year EBITDA was $52.6M.
The company maintained a gross profit margin of 65.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 25.3%.
Net profit margin reached 3.6% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for DR Corp. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

DR Corp Stock Performance

DR Corp has current market cap of CNY 13.0B (or $1.8B), and EV of CNY 8.9B (or $1.3B).

Market Cap Evolution

DR Corp Stock Data

As of October 17, 2025, DR Corp's stock price is CNY 32 (or $5).

See DR Corp trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.3B	$1.8B	XXX	XXX	XXX	XXX	$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

DR Corp Valuation Multiples

DR Corp's trades at 6.0x EV/Revenue multiple, and 23.8x EV/EBITDA.

See valuation multiples for DR Corp and 15K+ public comps

DR Corp Financial Valuation Multiples

As of October 17, 2025, DR Corp has market cap of $1.8B and EV of $1.3B.

Equity research analysts estimate DR Corp's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

DR Corp has a P/E ratio of 114.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.8B	XXX	$1.8B	XXX	XXX	XXX
EV (current)	$1.3B	XXX	$1.3B	XXX	XXX	XXX
EV/Revenue	5.7x	XXX	6.0x	XXX	XXX	XXX
EV/EBITDA	25.3x	XXX	23.8x	XXX	XXX	XXX
EV/EBIT	56.0x	XXX	-130.3x	XXX	XXX	XXX
EV/Gross Profit	8.8x	XXX	n/a	XXX	XXX	XXX
P/E	114.3x	XXX	244.3x	XXX	XXX	XXX
EV/FCF	n/a	XXX	202.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get DR Corp Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

DR Corp Margins & Growth Rates

DR Corp's last 12 month revenue growth is 8%

DR Corp's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

DR Corp's rule of 40 is 35% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

DR Corp's rule of X is 43% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for DR Corp and other 15K+ public comps

DR Corp Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	8%	XXX	7%	XXX	XXX	XXX
EBITDA Margin	23%	XXX	25%	XXX	XXX	XXX
EBITDA Growth	16%	XXX	-21%	XXX	XXX	XXX
Rule of 40	35%	XXX	33%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	43%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	15%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	70%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial